Pulmatrix (PULM) Interest Coverage Ratio (2014 - 2026)
Pulmatrix (PULM) posted Interest Coverage Ratio of 25.84 for Q1 2026, down 79153.1% sequentially from 0.03 in Q4 2025, and up 56.63% YoY from 16.5 in Q1 2025.
Pulmatrix (PULM) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Pulmatrix has reported Interest Coverage Ratio for 13 years, with the latest figure at 25.84 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 56.63% year-over-year to 25.84 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 92.28 (up 76.85% YoY) and the FY2025 annual result came in at 0.19, up 98.71% from the prior year.
- Interest Coverage Ratio eased to 25.84 in Q1 2026 per PULM's latest filing, from 0.03 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 20.6 in Q4 2023 and troughed at 110.71 in Q3 2024.
- A 5-year average of 25.0 and a median of 13.32 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio surged 305.78% in 2023, then slumped 113622.27% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 10.01 in 2022, then jumped by 305.78% to 20.6 in 2023, then sank by 637.37% to 110.71 in 2024, then soared by 99.97% to 0.03 in 2025, then plunged by 79153.1% to 25.84 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 25.84, 0.03, and 86.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.92 |
| Mar 31, 2026 | -25.84 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -86.60 |
| Jun 30, 2025 | -45.53 |
| Mar 31, 2025 | -59.58 |
| Sep 30, 2024 | -110.71 |
| Jun 30, 2024 | -18.33 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 20.60 |
| Sep 30, 2023 | -1.46 |
| Jun 30, 2023 | -9.24 |
| Mar 31, 2023 | -10.64 |
| Dec 31, 2022 | -10.01 |
| Sep 30, 2022 | -11.83 |
| Jun 30, 2022 | -14.80 |
| Mar 31, 2022 | -16.11 |
| Dec 31, 2021 | -13.57 |
| Sep 30, 2021 | -27.39 |
| Jun 30, 2021 | -12.87 |